Virtual Medicinal Product (VMP) - Spironolactone 5mg / Chlorothiazide 50mg capsules
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Spironolactone 5mg / Chlorothiazide 50mg capsules | Start Date 30-09-2014 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Name Basis
- Other
Codes
- ATC Code
- C03AH01
- BNF Codes
-
- BNF code 02020400
| Code | Start Date | End Date |
|---|---|---|
| 27810911000001102 | 30-09-2014 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Chlorothiazide | Based on Ingredient Substance | 50 mg | ||
| Spironolactone | Based on Ingredient Substance | 5 mg |
Name
Spironolactone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Name
Chlorothiazide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
Parent Products
-
VTMSpironolactone + Chlorothiazide
-
VMP(Current) Spironolactone 5mg / Chlorothiazide ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 capsule |